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Abstract 
 
Anticancer activity of secang’s heartwood (Caesalpinia sappan L.) is based on its main 
compound: brazilin and brazilein. Brazilin, brazilein, and other compounds such as 
caesalpiniaphenol can affect proteins that have a role in apoptosis. In this study, we observed 
cytotoxic activity of fraction containing brazilein (FCB) alone or in combination with 
chemotherapeutic agent, cisplatin and the ability of the combination to induce apoptosis in 
T47D breast cancer cell lines. Cytotoxicity assay was determined using MTT assay, whereas 
the detection apoptosis induction was conducted using flow cytometry using Annexin-V and 
propidium iodide. FCB and cisplatin showed cytotoxic effect on T47D cells with IC50 value of 
68 µg/mL and 16 µM, respectively. Combination of FCB and cisplatin result synergistic 
combination at the concentration ratio of 1/2 IC50 with CI value of 0.66. Its combination also 
able to induce apoptosis on T47D cell population 13% larger than the single treatment. 
Based on this study, we conclude that FCB is able to enhance the cytotoxic effects of 
cisplatin by inducing apoptosis. 
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INTRODUCTION 
 
Among women, breast cancer has the 
highest cancer incidence in seven Asian 
countries including Indonesia. Cisplatin is a 
chemotherapeutic agent that commonly used in 
the treatment of various types of cancer, 
including breast cancer (Tsimberidou, et al., 
2009; Dhar, et al., 2011). However, many 
anticancer drugs have narrow therapeutic index, 
so they can lead to multidrug resistance (MDR) 
(Ismael, et al., 2008). They also cause side 
effects such as nephrotoxicity, neurotoxicity 
(Milosavlievic, et al., 2010), and others. The 
use of co-chemotherapeutic agent combined 
with  chemotherapeutic agent can improve the 
effectiveness of cancer therapy as well as 
reduce side effects (Sharma, et al., 2004).  
One of the plants that potentially 
developed as an co-chemotherapeutic agent is 
secang’s heartwood (Caesalpinia sappan L.). 
Previous research proved that the main 
component of phenolic Caesalpinia sappan L., 
is homoisoflavonoid like brazilein, chalcone, 
protosappanin and brazilin (Yan, et al., 2005; 
Shimokawa, et al., 1985; Washiyama, et al., 
2009). Brazilein has cytotoxic effects on skin 
cancer cells to induce apoptosis through 
caspase-3-dependent (Liang, et al., 2013).  
This study observed the cytotoxic effect 
and apoptosis induction of fraction containing 
brazilein (FCB) and its combination with 
cisplatin against T47D breast cancer cells. By 
doing this research, the results is expected to be 
a reference for further research in order to 
explore compound/active fraction of secang’s 
heartwood as cisplatin co-chemotherapeutic 
agent in the breast cancer treatment. 
 
MATERIALS AND METHODS 
 
Sample Preparation 
FCB was obtained from the collection of 
Cancer Chemoprevention Research Center 
(CCRC), Universitas Gadjah Mada. Cisplatin 
(Wako) was used as chemotherapeutic agent 
with concentration 1 mg/mL.  
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Both FCB and cisplatin were diluted in various 
concentration using Dulbecco's Modified Eagle 
Medium (DMEM) high glucose culture 
medium before treated to the cell. FCB was 
dissolved first in dimethyl sulfoxide (DMSO) 
as co-solvent with final concentration 5 mg/mL. 
 
Cells Culture 
Human breast cancer T47D culture cells 
were collection of Cancer Chemoprevention 
Research Center (CCRC), Universitas Gadjah 
Mada. The cell line was kindly given by Prof. 
Kawaichi, Nara Institute of Science and 
Technology (NAIST), Japan. 
 
Chemicals 
T47D cell lines were cultured in DMEM 
high glucose (Invitrogen) with Fetal Bovine 
Serum (FBS) 10% (Gibco), penicilin-
streptomycin 1.5% (Gibco), and fungizone 
0.5% (Gibco). Trypsin-EDTA 0.25% (Gibco) 
was used to detach the cells from tissue culture 
dish. Phosphate buffer saline (PBS) was used as 
washing solution. DMSO (Sigma) was used to 
dissolve the test solution in concentration less 
than 1%. For cytotoxicity assay, MTT (3-[4,5-
dimethylthiazol-2-yl]-2,5diphenyl tetrazolium 
bromide) reagent (Sigma) 5 mg/mL was 
dissolved in DMEM medium. Sodium dodecyl 
sulfate (SDS)-HCl 0.01 N was used as stopper 
reagent. For apoptosis assay, we used reagent 
kit from Biovision.  
 
Cytotoxic Assay 
Cells (briefly 6x10
3
 cells/well) were 
transferred in to six well tissue culture plate 
(Iwaki) and incubated for 24 h. Cells were 
treated with FCB (concentration 20; 50; 75 and 
100 µg/mL), cisplatin (concentration 1; 2; 5; 
10; 15; and 30 µM), and their combination 
(concentration ratio 1/6; 1/3; and 1/2 IC50) and 
then incubated for 24 h. After 24 hours of 
incubation, medium was removed and cells 
were washed with 100 mL PBS. Then 100 mL 
MTT reagent with final concentration 0.5 
mg/mL in DMEM high glucose medium was 
added into each well and incubated again for 3-
4 hours to form formazan crystal. The stopper 
reagent (10% SDS in 0.01 N HCl) was used to 
dissolved and incubated overnight at room 
temperature and in the dark (covered with 
aluminum foil). The next day, the absorbance 
from each well was measured by ELISA reader 
with 595 nm wavelength.   
Apoptosis Assay 
Cells (briefly 3x10
5
 cells/well) were 
transferred in to six well tissue culture plate 
(Iwaki) and incubated for 24 h. Cells were 
treated with FCB, cisplatin, and their 
combination with concentration ½ IC50 and 
then incubated for 24 h. After incubation, 
adherent and detached cells were collected and 
centrifugated at 2000 rpm for 3 min, then 
washed twice with cold PBS. Then, PBS was 
discarded, conical was sealed with aluminum 
foil, and 500 mL of buffer Annexin-V were 
added to conical. AnnexinV and propidium 
iodide reagent were added respectively by 5 
mL, incubate for 5 minutes and analyzed by 
using flowcytometer (BD, FACS Calibur). 
 
Data Analysis  
Single cytotoxic assay. Cell viability was 
determined by percent viability. The calculation 
is [(absorbance of treated-drug) - (absorbance 
of medium)/(absorbance of control (untreated) 
cells - absorbance of medium)] × 100%. Linier 
regression between log concentration and % 
cell viability giving the equation Y = Bx + A 
were used to calculate IC50 value. The IC50 
values are defined as the drug concentrations 
required to reduce the absorbance by 50% of 
the control, Combinational cytotoxic assay, 
Drug Reduction Inex (DRI) and Combination 
Index (CI) was assessed by the Chou-Talalay 
method utilizing CompuSyn® software. 
 
RESULT AND DISCUSSION 
 
Cytotoxic assay was performed using 
MTT assay. The results indicated the 
occurrence of dose dependent manner. IC50 
value that obtained for FCB single treatment is 
68 µg/mL (Fig. 1). IC50 value that less than 100 
µg/mL indicates that FCB has potent cytotoxic 
effect against T47D cells (Omoyeni, et al., 
2014). When compared with methanolic extract 
of Caesalpinia sappan L., FCB also has more 
potent cytotoxic effect because the IC50 value 
from methanolic extract of Caesalpinia sappan 
L. was 150.9 µg/mL (Nurulita and Muflih, 
2006). Single treatment of cisplatin against 
T47D breast cancer cells was also conducted to 
determine the IC50 value. The IC50 value of 
cisplatin that obtained in this study is 16 µM 
(Fig.  2).   
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Figure 1. Cytotoxic effect of FCB on T47D cells. T47D cells (6x103 cells/well) were seeded in 96 wellplate 
and treated with FCB 20, 50, 75, and 100 µg/mL. Then plate was incubated for 24 hours and cells 
viability was determined by using MTT assay as described in methods. The higher concentration of FCB 
caused lower cells viability. Data were mean of two replications x ± SD (p<0,05). IC50 value was 
calculated using linier regression and FCB perform cytotoxicity with IC50 value of 68 µg/mL. 
 
 
 
Figure 2. Cytotoxic effect of cisplatin on T47D cells. T47D cells (6x103 cells/well) were seeded in 96 
wellplate and treated with cisplatin1, 2, 5, 10, 15, and 30 µM. Then plate was incubated for 24 hours and 
cells viability was determined by using MTT assay as described in methods. The higher concentration of 
cisplatin caused lower cells viability. Data were mean of two replications x ± SD (p<0,05). IC50 value was 
calculated using linier regression and cisplatin perform cytotoxicity with IC50 value of 16 µM. 
 
 
Combination of cisplatin and FCB 
possessed synergistic effect in concentration 
ratio 1/6; 1/3; and 1/2 IC50 (Table 1). The most 
synergistic effect was shown in concentration 
ratio 1/2 with CI value 0.66. Dose reduction 
index (DRI) value of FCB was 3.06, meant that 
FCB reduced the dose required when combined 
with cisplatin as much as 3.06 times (from 
63.81 µg/mL to 20.85 µg/mL). It also happened 
with cisplatin that reduced the dose as much as 
2.54 times (from 12.46 µM to 4.91 µM). DRI 
was occured in 50% inhibition of viable cells. 
Beside DRI, combination index (CI) value also 
be analyzed from compusyn. By looking CI 
value, the combination of drugs can be 
classified to synergistic, additive or antagonistic 
based on interactions. From CI values, the 
combination between cisplatin with FCB had 
synergistic effect because its CI value was less 
than 1 (for concentration ratio 1/2 IC50, 1/3 
IC50, and 1/6 IC50). The best CI value was 
occured when combined with concentration 
ratio 1/2 IC50 with CI value of 0.66 and 
decreased the percentage of cell viability up to 
23%. Cell morphology after treatment was 
observed.  There  were  cell  morphology 
change on treatment combination cisplatin and 
FCB with concentration ratio 1/4 and 1/2 IC50 
(Fig. 3B, 3C) compared with control cells (Fig. 
3A).  
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Tabel 1. Combination index (CI) and dose reduction index (DRI) values for FCB, cisplatin, 
and their combination. Data was obtained from compusyn software 
 
% sel hidup CI 
Fraksi Brazilein Cisplatin 
Konsentrasi (µg/mL) 
DRI 
Konsentrasi (µM) 
DRI 
Tunggal Kombinasi Tunggal Kombinasi 
95 1.02 30,30 5,26 5,76 1,47 1,24 1,18 
90 0.90 36,60 7,46 4,91 2,52 1,76 1,44 
75 0.78 48,33 12,47 3,87 6,61 2,94 1,91 
50 0.72 63,81 20,85 3,06 12,46 4,91 2,54 
30 0.71 79,06 31,00 2,55 23,07 7,29 3,16 
  
 
 
 
 
 
 
Figure 3. Combinational cytotoxic effect of FCB and cisplatin on T47D cells. T47D cells (6x103 cells/well) 
were seeded in 96 wellplate and treated with FCB and cisplatin in concentration ratio IC50 : IC50 (1/2; 
1/3; and 1/6 IC50). Then, plate was incubated for 24 hours and cells viability was determined by using 
MTT assay as described in methods. Combinational treatment altered cells morphology. Cells treated 
with (A) control cells, (B) combination with concentration ratio ¼ IC50, and (C) combination with 
concentration ratio ½ IC50. White arrows (       ) showed viable cells while black arrows (       ) showed 
death cells were observed under light microscope with 100x magnification. Graph (D) showed that 
combination of FCB and cisplatin decreased cells viability compared to cisplatin single treatment. 
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Cytotoxic activity of compound was 
correlated to its ability to induce apoptosis or 
inhibit cell cycle. Apoptosis assays’ result (Fig. 
4) showed that almost 90% of control cell 
population was not observed the presence of 
cell death. While on FCB treatment, apoptosis 
induction was observed as much as 80.59% of 
cell population. On cisplatin treatment, 
apoptosis induction observed by 80.86% of cell 
population. Meanwhile, the percentage of 
apoptotic cells in combination treatment was 
93.93%. It proved that combination treatment 
of FCB and cisplatin with 24 hour incubation 
enhance the ability of cisplatin to induced 
apoptosis as much as 13% on T47D breast 
cancer cells. 
 
 
 
 
 
Figure 4. Effect of combination FCB-cisplatin on T47D cells apoptosis. T47D cells were seeded at 3x105 
cells/well on 6 wells tissue culture plate, then treated with FCB ½ IC50 alone and its combination with 
cisplatin ½ IC50. After 24 hours of incubation, cells were harvested as described in methods, added with 
AnnexinV and PI reagent, then subjected to FACS flowcytometry. Flowcytometric profile of cells treated 
with (A) control, (B) FCB, (C) cisplatin, and (D) combination of FCB and cisplatin. There are 4 quadrans: 
lower left (LL) indicates viable cells, lower right (LR) indicating early apoptotic cells, upper left (UL) 
indicating late apoptotic cell, upper right (UR) indicating necrotic cells. Graph (E) showed the percentage 
of viability cell of combination FCB and cisplatin induce apoptosis. 
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T47D breast cancer cell lines expreses 
caspase-3 wildtype, caspase-7 wildtype, mutant 
p53 and ER/PR-positive (Bouker, et al., 2005; 
Schafer, et al., 2000). In fact, p53 tumor 
suppressor gene is a gene that plays a role in 
apoptosis. This p53 gene stimulates expression 
of Bcl-2 family including Bax, and can bind to 
one or more anti-apoptotic proteins in 
mitochondria, such as Bcl-XL (Chipuk, et al., 
2003; Marsden, et al., 2002). On the other 
hand, cisplatin also plays a role in mediating 
the activation of the p53 protein, which is 
followed by the occurrence of DNA damage 
(Tanida, et al., 2012), so the mutation of p53 
gene on T47D cells can inhibit cisplatin to 
induce apoptosis. However, previous studies 
had proved that the mechanism of cisplatin to 
induce apoptosis was by causing down-
regulation of Bcl-2 gene on MCF 7 cell lines 
(Thomadaki and Scorilas 2007) and T47D cell 
lines (Mokhtari, et al., 2012). Other studies had 
also demonstrated the expression of Bcl-2, Bcl-
XL, BAD and BAX was regulated by cisplatin 
(Siervo-Sassi, et al., 2003). So, that is the 
reason of cisplatin still can induce apoptosis on 
T47D cell lines, which is expresses mutant p53. 
Cytotoxic activity of FCB on T47D cells 
was expected to be caused by active compounds 
contained in these fractions, namely brazilin 
and brazilein. Cytotoxic mechanism of 
combination FCB and cisplatin occured through 
apoptosis induction. Apoptosis induction of 
FCB alone might be related to the mechanism 
of apoptosis induction from p53 independent. 
Brazilin which is the main compound from 
secang’s heartwood can activate caspase-3 and 
regulate the expression of Bcl-2 family 
proteins, including Bax, Bcl-x (L), and Bcl-2 on 
U 266 myeloma cancer cells (Kim, et al., 
2012). Brazilin also known could inhibit 
proliferation of glioblastoma cells (Yen, et al., 
2010) and induce apoptosis on glioblastoma 
cells through activation of caspase-3, followed 
by poly-(ADP)-ribose polymerase (PARP) 
cleavage and through the induction of caspase -
7 (Lee, et al., 2013; Hengartner, 2000). In 
addition, brazilin also increased the population 
of glioblastoma cells in cell cycle sub-G1 area 
(Lee, et al., 2013). While the other major 
compound of secang’s heartwood, like 
brazilein, also known could increase the 
activation of caspase-9 and caspase-3, induce 
PARP cleavage and cause down-regulation of 
survivin protein on HepG2 liver cancer cells 
(Zhong, et al., 2009). On MCF-7 breast cancer 
cells, brazilein also could induce apoptosis 
through inhibition of survivin expression (Tao, 
et al., 2011). Brazilein also could inhibit NF-κB 
activation via PI3K/Akt pathway inactivation 
and p38 MAPK on MDA-MB-23 cells (Hsieh, 
et al., 2013). These mechanisms might be 
responsible in apoptosis induction of secang’s 
heartwood on T47D cell lines. Thus, further 
study is still needed to be conducted. 
 
CONCLUSION 
 
We summarized that FCB is able to 
enhance the cytotoxic effects of cisplatin by 
inducing apoptosis 
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